Advertisement
Table 2 Changes in clinical serum chemistry and complete blood count variables
From: Efficacy and safety of a popular thermogenic drink after 28 days of ingestion
| Variable | Group | Day 0 | Day 28 | Significance | |
|---|---|---|---|---|---|
| Triglycerides (mg·dl-1) | TD PLA | 94 ± 8 94 ± 7 | 105 ± 9 98 ± 7 | Group: Time: G × T: | 0.77 0.10 0.44 |
| Total Chol (mg·dl-1) | TD PLA | 162 ± 5 165 ± 6 | 164 ± 5 168 ± 5 | Group: Time: G × T: | 0.61 0.32 0.99 |
| HDL Chol (mg·dl-1) | TD PLA | 58 ± 3 54 ± 2 | 57 ± 3 54 ± 2 | Group: Time: G × T: | 0.33 0.92 0.44 |
| LDL Chol (mg·dl-1) | TD PLA | 85 ± 4 94 ± 6 | 86 ± 5 94 ± 5 | Group: Time: G × T: | 0.26 0.73 0.91 |
| Glucose (mg·dl-1) | TD PLA | 94 ± 1 91 ± 1 | 96 ± 1 92 ± 1 | Group: Time: G × T: | 0.07 0.06 0.52 |
| Sodium (mM)† | TD PLA | 141 ± 1 141 ± 1 | 142 ± 2 142 ± 2 | Group: Time: G × T: | 0.93 0.03 0.96 |
| Potassium (mM) | TD PLA | 4.4 ± 0.1 4.5 ± 0.1 | 4.5 ± 0.1 4.6 ± 0.1 | Group: Time: G × T: | 0.20 0.41 0.96 |
| BUN (mg·dl-1) | TD PLA | 14 ± 1 14 ± 1 | 14 ± 1 13 ± 1 | Group: Time: G × T: | 0.63 0.35 0.36 |
| Creatinine (mg·dl-1)† | TD PLA | 1.0 ± 0.0 1.0 ± 0.0 | 1.0 ± 0.0 1.0 ± 0.0 | Group: Time: G × T: | 0.46 0.007 0.42 |
| ALT (U·L-1) | TD PLA | 20 ± 2 19 ± 1 | 18 ± 1 18 ± 1 | Group: Time: G × T: | 0.69 0.12 0.51 |
| AST (U·L-1) | TD PLA | 20 ± 1 20 ± 1 | 20 ± 1 21 ± 2 | Group: Time: G × T: | 0.94 0.53 0.74 |
| RBC Count (106·μl-1)† | TD PLA | 5.00 ± 0.12 4.91 ± 0.14 | 4.63 ± 0.08 4.62 ± 0.10 | Group: Time: G × T: | 0.75 < 0.001 0.68 |
| Hemoglobin (g·dl-1)† | TD PLA | 14.5 ± 0.2 14.8 ± 0.3 | 14.2 ± 0.2 14.4 ± 0.3 | Group: Time: G × T: | 0.42 0.003 0.50 |
| Hematocrit (%)† | TD PLA | 43.6 ± 1.6 42.7 ± 0.8 | 40.8 ± 0.7 41.0 ± 0.9 | Group: Time: G × T: | 0.78 0.02 0.56 |
| WBC Count (103·μl-1) | TD PLA | 5.9 ± 0.2 5.9 ± 0.2 | 5.8 ± 0.2 6.1 ± 0.2 | Group: Time: G × T: | 0.63 0.95 0.36 |
